Literature DB >> 10321756

Intestinal permeability and liver disease.

M A Aldersley1, P D Howdle.   

Abstract

Increased intestinal permeability has for many years been implicated as a possible contributory factor in the development of encephalopathy and spontaneous bacterial peritonitis (SBP) seen in patients with cirrhosis. The majority of studies indicate that there is an increase in small intestinal permeability in cirrhotic patients and there is also evidence of an increase in patients with acute liver failure. The cause of these changes is unknown and whether they are related to the development of SBP and encephalopathy is unclear.

Entities:  

Mesh:

Year:  1999        PMID: 10321756     DOI: 10.1097/00042737-199904000-00007

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  7 in total

Review 1.  Infection, coagulation, and variceal bleeding in cirrhosis.

Authors:  U Thalheimer; C K Triantos; D N Samonakis; D Patch; A K Burroughs
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

2.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

3.  Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases.

Authors:  Anastasios E Germenis; Efthalia E Yiannaki; Kalliopi Zachou; Violeta Roka; Sotirios Barbanis; Christos Liaskos; Kalliopi Adam; Andreas N Kapsoritakis; Spyros Potamianos; Georgios N Dalekos
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

4.  Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats.

Authors:  Xi Jin; Chao-Hui Yu; Guo-Cai Lv; You-Ming Li
Journal:  World J Gastroenterol       Date:  2007-03-21       Impact factor: 5.742

Review 5.  Immune Dysfunction in Cirrhosis.

Authors:  Mohd Talha Noor; Piyush Manoria
Journal:  J Clin Transl Hepatol       Date:  2017-03-10

Review 6.  Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step.

Authors:  Hiroshi Fukui
Journal:  J Clin Transl Hepatol       Date:  2017-06-29

Review 7.  Management of refractory cirrhotic ascites: challenges and solutions.

Authors:  Hiroshi Fukui; Hideto Kawaratani; Kosuke Kaji; Hiroaki Takaya; Hitoshi Yoshiji
Journal:  Hepat Med       Date:  2018-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.